Pulse Biosciences, Inc (PLSE) financial statements (2022 and earlier)

Company profile

Business Address 3957 POINT EDEN WAY
HAYWARD, CA 94545
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:28,60012,4636,89951,10338,06916,395
Cash and cash equivalents28,61412,4636,89951,1033,3862,089
Short-term investments    34,68314,306
Other undisclosed cash, cash equivalents, and short-term investments(14)     
Receivables61     
Inventory, net of allowances, customer advances and progress billings5,824     
Inventory5,824     
Other undisclosed current assets2,1459,87619,5049,259412268
Total current assets:36,63022,33926,40360,36238,48116,663
Noncurrent Assets
Operating lease, right-of-use asset8,7859,4385,114
Property, plant and equipment2,4622,4782,5662,1732,570317
Intangible assets, net (including goodwill)6,0076,6737,3388,0048,6699,334
Goodwill2,7912,7912,7912,7912,7912,791
Intangible assets, net (excluding goodwill)3,2163,8824,5475,2135,8786,543
Other noncurrent assets365365494101101 
Total noncurrent assets:17,61918,95415,51210,27811,3409,651
TOTAL ASSETS:54,24941,29341,91570,64049,82126,314
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,2937,0434,4592,6931,8161,016
Accounts payable2,9041,7171,9631,272782265
Accrued liabilities4,3895,3262,4961,4211,034751
Deferred revenue16  
Debt436     
Deferred rent credit   415
Deferred revenue and credits397 
Other undisclosed current liabilities774542    
Total current liabilities:8,5197,5854,4593,1082,2131,016
Noncurrent Liabilities
Long-term debt and lease obligation10,04010,8146,719   
Operating lease, liability10,04010,8146,719
Liabilities, other than long-term debt   1,1981,613 
Deferred revenue and credits1,613 
Deferred rent credit   1,198
Other undisclosed noncurrent liabilities(10,040)(10,814)    
Total noncurrent liabilities:10,04010,8146,7191,1981,613 
Total liabilities:18,55918,39911,1784,3063,8261,016
Stockholders' equity
Stockholders' equity attributable to parent35,69022,89430,73766,33445,99525,298
Common stock292521211713
Additional paid in capital271,861195,410153,401142,03284,20237,898
Accumulated other comprehensive income (loss) (1)4(1)(51)(7)
Accumulated deficit(236,200)(172,540)(122,689)(75,718)(38,173)(12,606)
Total stockholders' equity:35,69022,89430,73766,33445,99525,298
TOTAL LIABILITIES AND EQUITY:54,24941,29341,91570,64049,82126,314

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues1,41811498344624768
Net investment income 11498344624768
Cost of revenue(1,968)(500)(600)(600)(800)(500)
Cost of goods and services sold(600)(500)(600)(600)(800)(500)
Gross profit:(550)(386)383(154)(553)(432)
Operating expenses(62,464)(49,965)(47,954)(37,963)(25,814)(9,586)
Other undisclosed operating income 500600572800500
Operating loss:(63,014)(49,851)(46,971)(37,545)(25,567)(9,518)
Nonoperating expense(646)(5)    
Investment income, nonoperating(13)(5)    
Other undisclosed income from continuing operations before equity method investments, income taxes 5    
Loss from continuing operations before income taxes:(63,660)(49,851)(46,971)(37,545)(25,567)(9,518)
Income tax expense (3)    
Net loss:(63,660)(49,854)(46,971)(37,545)(25,567)(9,518)
Other undisclosed net income attributable to parent 3    
Net loss available to common stockholders, diluted:(63,660)(49,851)(46,971)(37,545)(25,567)(9,518)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(63,660)(49,854)(46,971)(37,545)(25,567)(9,518)
Comprehensive loss:(63,660)(49,854)(46,971)(37,545)(25,567)(9,518)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(2)550(44)(7)
Comprehensive loss, net of tax, attributable to parent:(63,659)(49,856)(46,966)(37,495)(25,611)(9,525)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: